Na Dong

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

China Pharmaceutical University(Current)

Second Affiliated Hospital of Nanjing Medical University

Na Dong is an author at China Pharmaceutical University specializing in antiepileptic pharmacotherapy, epilepsy in childhood, and clinical pharmacology.

ORCID

Publications per year

2020–2023

Publications

Potentially inappropriate medications in Chinese older adults: a comparison of two updated Beers criteria

Dan He, Huaijun Zhu, Hai-Hui Zhou et al. · International Journal of Clinical Pharmacy · 2020 · 26 citations

Pharmacy, Geriatric Medicine, Pharmacy Practice +14

Integrating metabolomics and lipidomics revealed a decrease in plasma fatty acids but an increase in triglycerides in children with drug‐refractory epilepsy

Hong‐Li Guo, Weijun Wang, Na Dong et al. · Epilepsia Open · 2023 · 26 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +16

Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio

Yue Li, Na Dong, Yu‐Xin Qin et al. · Epilepsia Open · 2022 · 21 citations · Full text

Medicine, Pediatrics, Pharmacology +17

Plasma lacosamide monitoring in children with epilepsy: Focus on reference therapeutic range and influencing factors

Yue Li, Hong‐Li Guo, Yuan‐Yuan Zhang et al. · Frontiers in Pediatrics · 2022 · 13 citations · Full text

Medicine, Pediatrics, Pharmacology +15

1–4 of 4